MP54-14 SEQUENTIAL INTRAVESICAL GEMCITABINE/DOCETAXEL PROVIDES A DURABLE REMISSION IN RECURRENT HIGH RISK NMIBC FOLLOWING BCG THERAPY. (May 2022) - Yim, Kendrick; Melnick, Kevin; Mott, Sarah L.; Gupta, Vani; Clinton, Timothy N.; Carvalho, Filipe L.F.; Mossanen, Matthew; Steele, Graeme S.; Mouw, Kent; O'Donnell, Michael A.; Preston, Mark A.